Der p house dust mite allergen immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Der p house dust mite allergen immunotherapy, covering 2013-03-01 to 2013-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Immunological Changes and Clinical Efficacy of Specific Immunotherapy With Der p House Dust Mite Allergen in Polysensitized and Monosensitized Patients With Allergic Rhinitis and/or Asthma.